388 related articles for article (PubMed ID: 21466776)
1. [Level of evidence for therapeutic drug monitoring of aminoglycosides].
Venisse N; Boulamery A;
Therapie; 2011; 66(1):39-44. PubMed ID: 21466776
[TBL] [Abstract][Full Text] [Related]
2. [Level of evidence for therapeutic drug monitoring of teicoplatin].
Boulamery A; Venisse N; Le Guellec C;
Therapie; 2011; 66(1):45-50. PubMed ID: 21466777
[TBL] [Abstract][Full Text] [Related]
3. [Level of evidence for therapeutic drug monitoring of vancomycin].
Jelassi ML; Benlmouden A; Lefeuvre S; Mainardi JL; Billaud EM;
Therapie; 2011; 66(1):29-37. PubMed ID: 21466775
[TBL] [Abstract][Full Text] [Related]
4. [Not Available].
Venisse N; Boulamery A;
Therapie; 2011; 66(1):39-44. PubMed ID: 27393463
[TBL] [Abstract][Full Text] [Related]
5. [Cost-effectiveness analysis of active TDM in elderly patients treated with aminoglycosides].
Leon-Djian CB; Bourguignon L; Späth HM; Maire P
Therapie; 2011; 66(5):445-52. PubMed ID: 22031689
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring.
Croes S; Koop AH; van Gils SA; Neef C
Eur J Pharm Sci; 2012 Jan; 45(1-2):90-100. PubMed ID: 22094306
[TBL] [Abstract][Full Text] [Related]
7. [Which partner for the betalactam agent in empirical combined therapy? II. Aminoglycoside].
Mimoz O; Grollier G
Ann Fr Anesth Reanim; 2004 Jun; 23(6):639-42. PubMed ID: 15234735
[No Abstract] [Full Text] [Related]
8. Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity.
Avent ML; Rogers BA; Cheng AC; Paterson DL
Intern Med J; 2011 Jun; 41(6):441-9. PubMed ID: 21309997
[TBL] [Abstract][Full Text] [Related]
9. [Aminoglycoside antibiotics].
Kubo H; Shinozaki K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():427-31. PubMed ID: 15658355
[No Abstract] [Full Text] [Related]
10. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.
Kusowska J
Acta Pol Pharm; 2005; 62(6):491-5. PubMed ID: 16583990
[TBL] [Abstract][Full Text] [Related]
11. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.
Kusowska J
Acta Pol Pharm; 2005; 62(6):485-90. PubMed ID: 16583989
[TBL] [Abstract][Full Text] [Related]
12. [Aminoglycosides are effective--but oto- and nephrotoxic. Knowledge base from the reference group for antibiotic issues on benefit-risk with aminoglycosides].
Ternhag A; Giske CG; Hanberger H
Lakartidningen; 2014 Feb 12-18; 111(7):268-9. PubMed ID: 24669487
[No Abstract] [Full Text] [Related]
13. Therapeutic drug monitoring of aminoglycosides in neonates.
Touw DJ; Westerman EM; Sprij AJ
Clin Pharmacokinet; 2009; 48(2):71-88. PubMed ID: 19271781
[TBL] [Abstract][Full Text] [Related]
14. [Aminoglycosides and polymyxins].
Molina J; Cordero E; Palomino J; Pachón J
Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):178-88. PubMed ID: 19303668
[TBL] [Abstract][Full Text] [Related]
15. Aminoglycosides: a practical review.
Gonzalez LS; Spencer JP
Am Fam Physician; 1998 Nov; 58(8):1811-20. PubMed ID: 9835856
[TBL] [Abstract][Full Text] [Related]
16. Aminoglycoside therapy in infectious diseases.
Poulikakos P; Falagas ME
Expert Opin Pharmacother; 2013 Aug; 14(12):1585-97. PubMed ID: 23746121
[TBL] [Abstract][Full Text] [Related]
17. Back to the future: using aminoglycosides again and how to dose them optimally.
Drusano GL; Ambrose PG; Bhavnani SM; Bertino JS; Nafziger AN; Louie A
Clin Infect Dis; 2007 Sep; 45(6):753-60. PubMed ID: 17712761
[TBL] [Abstract][Full Text] [Related]
18. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
Prescott WA; Nagel JL
Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
[TBL] [Abstract][Full Text] [Related]
19. [Level of evidence for therapeutic drug monitoring of ceftriaxone].
Dailly E; Verdier MC; Deslandes G; Bouquié R; Tribut O; Bentué-Ferrer D
Therapie; 2012; 67(2):145-9. PubMed ID: 22850101
[TBL] [Abstract][Full Text] [Related]
20. [Is therapeutic drug monitoring (TDM) in paediatric patients necessary?].
Prokopczyk J; Piekarczyk A; Kaminska E
Med Wieku Rozwoj; 2001; 5(2):149-55. PubMed ID: 11679679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
